| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,572,897 | 1,580,042 | 1,806,389 | 1,786,426 | | Cost of Revenue | 712,453 | 700,737 | 730,091 | 772,277 | | | Gross Profit | 860,444 | 879,305 | 1,076,298 | 1,014,149 | | | Operating Expenses | | Research Development | 291,398 | 306,043 | 278,290 | 323,172 | | Selling General and Administrative | 419,038 | 458,109 | 482,493 | 596,575 | | Non Recurring | 65,002 | 4,801 | 577,506 |
-
| | Others | 9,253 | 9,667 | 16,358 | 24,228 | | | | Total Operating Expenses | 784,691 | 778,620 | 1,354,647 |
-
| | | | Operating Income or Loss | 75,753 | 100,685 | (278,349) | 70,174 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 72,010 | 4,960 | 25,621 | 8,881 | | Earnings Before Interest And Taxes | 147,763 | 105,645 | (252,728) | 79,055 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 147,763 | 105,645 | (252,728) | 79,055 | | Income Tax Expense | 68,879 | 35,884 | 107,474 | 50,577 | | Minority Interest | (48,934) | 48,934 | (2,734) | (1,892) | | | | Net Income From Continuing Ops | 143,040 | 118,695 | (303,428) | 54,348 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 143,040 | 118,695 | (303,428) | 54,348 | | Preferred Stock And Other Adjustments | (1,653) | (1,137) |
-
|
-
| | | Net Income Applicable To Common Shares | $141,387 | $117,558 | ($303,428) | $54,348 |
|
0.27% Nasdaq 
Income Statement
